Achieve Life Sciences (ACHV) Stock Forecast & Price Target

$4.34 +0.18 (+4.33%)

(As of 11/19/2024 ET)

Achieve Life Sciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 6 Analyst Ratings

Sell
0

Hold
0

Buy
6

Based on 6 Wall Street analysts who have issued ratings for Achieve Life Sciences in the last 12 months, the stock has a consensus rating of "Buy." Out of the 6 analysts, 4 have given a buy rating, and 2 have given a strong buy rating for ACHV.

Consensus Price Target

$14.80
241.01% Upside

According to the 6 analysts' twelve-month price targets for Achieve Life Sciences, the average price target is $14.80. The highest price target for ACHV is $20.00, while the lowest price target for ACHV is $11.00. The average price target represents a forecasted upside of 241.01% from the current price of $4.34.

Get the Latest News and Ratings for ACHV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Achieve Life Sciences and its competitors.

ACHV Analyst Ratings Over Time

Type	Current Forecast 11/21/23 to 11/20/24	1 Month Ago 10/22/23 to 10/21/24	3 Months Ago 8/23/23 to 8/22/24	1 Year Ago 11/21/22 to 11/21/23
Strong Buy	2 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$14.80	$15.50	$14.00	$18.67
Forecasted Upside	241.01% Upside	211.24% Upside	217.82% Upside	254.21% Upside
Consensus Rating	Buy	Buy	Buy	Buy

Former Trump advisor releases terrifying warning (Ad)

Goldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most important financial story of the decade. Goldman Sachs, the IMF, JP Morgan, Bank of America, and Morgan Stanley have issued warnings. Yet most ordinary Americans have no idea. Now one former Trump advisor is sounding the alarm. “If people knew the full facts, there’d be blood in the streets.”

Get the facts and learn how to protect your family now.

ACHV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ACHV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Achieve Life Sciences Stock vs. The Competition

Type	Achieve Life Sciences	Medical Companies	S&P 500
Consensus Rating Score	3.33	2.80	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	241.01% Upside	28,037.40% Upside	9.98% Upside
News Sentiment Rating	Neutral News See Recent ACHV News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/14/2024	RODMAN&RENSHAW 0 of 5 stars	B. Folkes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
11/14/2024	Rodman & Renshaw 1 of 5 stars		Initiated Coverage	Buy	$12.00	+164.90%
9/27/2024	Raymond James 4 of 5 stars		Initiated Coverage	Strong-Buy	$20.00	+350.45%
8/15/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$11.00 ➝ $11.00	+150.00%
4/17/2024	Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$20.00	+340.53%
3/5/2024	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$19.00 ➝ $11.00	+148.87%
5/10/2023	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason McCarthy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy	$8.00 ➝ $20.00	+115.75%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:39 AM ET.

ACHV Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Achieve Life Sciences is $14.80, with a high forecast of $20.00 and a low forecast of $11.00.
: 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last year. There are currently 4 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ACHV shares.
: According to analysts, Achieve Life Sciences's stock has a predicted upside of 241.01% based on their 12-month stock forecasts.
: Over the previous 90 days, Achieve Life Sciences's stock had 1 upgrade by analysts.
: Achieve Life Sciences has been rated by research analysts at Raymond James, Rodman & Renshaw, and RODMAN&RENSHAW in the past 90 days.
: Analysts like Achieve Life Sciences more than other "medical" companies. The consensus rating for Achieve Life Sciences is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ACHV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

This page (NASDAQ:ACHV) was last updated on 11/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Achieve Life Sciences (ACHV) Stock Forecast & Price Target